Adding Magnesium Sulfate to Bupivacaine for Ilioinguinal and Iliohypogastric Nerve Block
NCT ID: NCT05158647
Last Updated: 2021-12-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
90 participants
INTERVENTIONAL
2018-08-12
2020-04-21
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
control group
10-ml 0.5% isobaric bupivacaine and 1ml normal saline were prepared for IIIH blockade
normal saline
10-ml 0.5% isobaric bupivacaine and 1ml normal saline were prepared for IIIH blockade
MgSo4 group
10 ml 0.5% isobaric bupivacaine and 1ml of MgSo4 10% (100 mg) were used.
MgSo4
10 ml 0.5% isobaric bupivacaine and 1ml of MgSo4 10% (100 mg) were used
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
normal saline
10-ml 0.5% isobaric bupivacaine and 1ml normal saline were prepared for IIIH blockade
MgSo4
10 ml 0.5% isobaric bupivacaine and 1ml of MgSo4 10% (100 mg) were used
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* American Society of Anesthesiologists physical status I or II
Exclusion Criteria
* allergy to the study drugs
* on chronic analgesics or drug containing magnesium
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Abdelrady S Ibrahim, MD
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Abdelrady S Ibrahim, MD
Professor Of Anesthesia and ICU
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mahmoud S Elmansy
Role: PRINCIPAL_INVESTIGATOR
Faculty of Medicine Mansoura University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mahmoud S Elmansy
Al Mansurah, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Carre P, Mollet J, Le Poultel S, Costey G, Ecoffey C. [Ilio-inguinal Ilio-hypogastic nerve block with a single puncture: an alterantive for anesthesia in emergency inguinal surgery]. Ann Fr Anesth Reanim. 2001 Aug;20(7):643-6. doi: 10.1016/s0750-7658(01)00425-7. French.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB0000871250
Identifier Type: -
Identifier Source: org_study_id